In 2022, the FDA added Wegovy (semaglutide), Ozempic (semaglutide) and Mounjaro (tirzepatide) to the FDA drug shortage list, followed by Zepbound (tirzepatide) in 2024
All medications are HSA/FSA eligible, making treatment accessible to uninsured and underinsured patients across all 50 states
For example, Novo Nordisk now offers a monthly supply of Wegovy for $349 for eligible patients through NovoCare Pharmacy
Our hair growth protocols combine the 4 peptides above, often stacked with microneedling, Minoxidil, Finasteride, or PRP depending on the patient
Pairing it with a structured plan, like Noom, can make those habits second nature so your results last well beyond the injections
The same toxin also treats masseter jaw-slimming and axillary hyperhidrosis, both detailed on the national Botox procedure hub